A new genetic study offers glimpses into how scientists might use gene-sequencing data to customize pediatric patients’ cancer treatments.
Category Archive: Cancer
Permanent link to this article: http://www.research.chop.edu/blog/genetic-study-suggests-fine-tuning-drugs-for-pediatric-brain-tumors/
Apr 02 2013
AACR Academy Inaugurates Tom Curran, PhD, FRS into First Class of Fellows
Tom Curran, PhD, FRS, Deputy Scientific Director of The Children’s Hospital of Philadelphia Research Institute, will be formally inducted into the AACR Academy on April 5 in Washington, D.C.
Permanent link to this article: http://www.research.chop.edu/blog/aacr-academy-inaugurates-tom-curran-phd-frs-into-first-class-of-fellows/
Mar 26 2013
Advanced Cell Therapy Eliminates Aggressive Leukemia in Two Children
According to new research from The Children’s Hospital of Philadelphia and the University of Pennsylvania, two children with an aggressive form of childhood leukemia achieved a complete response after being treated with an innovative cell therapy.
Permanent link to this article: http://www.research.chop.edu/blog/advanced-cell-therapy-eliminates-aggressive-leukemia-in-two-children/
Mar 20 2013
CHOP Investigator Sheds Light on Effects of Sequestration on Cancer Research
CHOP’s Peter Adamson, MD, who heads the Children’s Oncology Group, the largest organization in the world dedicated to childhood and adolescent cancer research, was recently interviewed by journalist Paul Goldberg for the March 15 issue of The Cancer Letter.
Permanent link to this article: http://www.research.chop.edu/blog/chop-investigator-sheds-light-on-effects-of-sequestration-on-cancer-research/
Jan 24 2013
Study Shows Neuroblastoma Evolves Rapidly, Limiting Treatment Targets
A recent genomic study of neuroblastoma reinforces the challenges of treating the most aggressive forms of this disease. Contrary to expectations, the researchers found relatively few recurrent gene mutations — mutations that would suggest new targets for neuroblastoma treatment. Instead, the investigators have refocused on how neuroblastoma tumors evolve in response to medicine and other factors.
Permanent link to this article: http://www.research.chop.edu/blog/study-shows-neuroblastoma-evolves-rapidly-limiting-treatment-targets/
Jan 23 2013
Cellie Cancer Coping Kit: It’s Much More Than a Toy
It’s Cellie! To be more specific, it’s the Cellie Cancer Coping Kit, a tool designed by Children’s Hospital of Philadelphia researchers to help children and their families manage the physical and emotional challenges associated with cancer treatment. In addition to Cellie, the namesake plush toy — or critter, as some of the researchers who work with Cellie call it — the kit also includes a pack of “cancer coping cards” and a booklet for caregivers.
Permanent link to this article: http://www.research.chop.edu/blog/cellie-cancer-coping-kit-its-much-more-than-a-toy/
Jan 11 2013
Childhood Brain Tumors at Center of New Research Collaboration
The Children’s Hospital of Philadelphia and China-based BGI-Shenzhen are now collaborating on research into next-generation sequencing to analyze pediatric brain tumors.
Permanent link to this article: http://www.research.chop.edu/blog/childhood-brain-tumors-at-center-of-new-research-collaboration/
Dec 13 2012
Fire with Fire
We had to share — check out this amazing Focus Forward film on the recent T cell therapy treatment!
Permanent link to this article: http://www.research.chop.edu/blog/fire-with-fire/
Dec 12 2012
A Year in Review
The holiday season is once again upon us! While it’s a time for family and friends to gather, indulge in traditions, and celebrate this season of giving, it’s also hard to believe another year has passed. In another “I can’t believe it’s already here” tradition, the new edition of the Children’s Hospital of Philadelphia Research …
Permanent link to this article: http://www.research.chop.edu/blog/a-year-in-review/
Dec 09 2012
Leukemia Patient Cancer-Free After Novel Treatment With Engineered Immune Cells
Cancer therapy for children has come a long way over the last several decades, and the cure rate for some forms of pediatric cancer is at an all-time high. Although this success rate offers tremendous hope and optimism, there are some children whose disease fails to respond to conventional treatment, leaving doctors to explore novel …
Permanent link to this article: http://www.research.chop.edu/blog/leukemia-patient-cancer-free-after-novel-treatment-with-engineered-immune-cells/
Subscribe to Cornerstone
Loading tweets...
Recent Comments